NCT06350370 Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
| NCT ID | NCT06350370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2023-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,000 participants in total. It began in 2019-01-01 with a primary completion date of 2023-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Natural orifice specimen extraction surgery (NOSES) has gained widespread recognition among scholars and has gradually been promoted and popularized around the world. However, the development of NOSES is still in the exploratory stage and there is a lack of strong evidence from evidence-based medicine to support its feasibility and safety, which has greatly affected its clinical application and development. Based on this, at the call of Professor Xishan Wang, the Chinese NOSES Alliance conducted a large retrospective clinical study involving multiple centers. By summarizing the NOSES cases of nearly 100 centers in China, the study aims to clarify the current status of NOSES surgery in China. Additionally, a comprehensive analysis and summary was conducted by combining the basic information of NOSES patients, perioperative data, postoperative pathological data, and follow-up information to further demonstrate the safety and feasibility of NOSES in the treatment of colorectal cancer. This study also provides more real and objective evidence-based medicine support for the promotion and development of NOSES surgery.
Eligibility Criteria
Inclusion Criteria: 1. Pathological diagnosis of primary malignant tumor in the colon or rectum; 2. The surgery meets the definition in the "Consensus of NOSES Experts in Colorectal Cancer"; Exclusion Criteria: 1. Postoperative pathological diagnosis does not belong to primary malignant tumors in the colon or rectum; 2. The surgery does not meet the definition in the "Consensus of NOSES Experts in Colorectal Cancer".
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06350370 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06350370 currently recruiting?
Yes, NCT06350370 is actively recruiting participants. Contact the research team at wxshan_cams@163.com for enrollment information.
Where is the NCT06350370 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06350370 clinical trial?
NCT06350370 is sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. The trial plans to enroll 8,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.